REGENXBIO’s Gene Therapy Updates for Hunter Syndrome and DMD
REGENXBIO was co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform
Vivodyne was co-founded by Dan Huh, PhD, Professor of Bioengineering in Penn Engineering and CEO Andrei Georgescu.,
Smart Dental Implant Developed by Penn Researchers
Researchers developed a smart dental implant that prevents gum inflammation and plaque formation.
World’s First Patient Treated with Personalized CRISPR Gene Editing Therapy through Penn Medicine and CHOP Collaboration
In a history-making breakthrough, a baby diagnosed with a rare genetic disorder was successfully treated with a customized CRISPR gene editing therapy.
Penn Engineering Hosts “AI at the Crossroads: Ethics, Innovation & Impact” During Philly Tech Week
Melissa Kelly, PhD, Deputy Managing Director of PCI, served as a panelist and shared her insights on the impact of AI.
AI Across Disciplines Event Highlights Penn’s Role in Shaping AI
At a cross-disciplinary gathering at Amy Gutmann Hall, the Penn community celebrated the launch of the Penn AI Initiative with a panel discussing AI research at Penn.
Academic Entrepreneurship the Focus of Recent Speaker Series
Bryan presented on "Software as a Medical Device” and shared his journey co-founding Galileo CDS.
Penn Medicine’s Jake Brenner Develops State-of-the-art DNA-Delivery Technology
By safely delivering therapeutic DNA to cells, this technology has the potential to transform treatment for common chronic diseases.
Cesar de la Fuente’s AI Breakthroughs Could Help Predict the Next Pandemic
Recently, Dr. de la Fuente’s lab has been working on developing new antibiotics and exploring prehistoric proteins that could be repurposed to fight modern diseases
2025 President’s Innovation Prize Winner Announced
The team is developing a privacy-centric AI system to support eldercare by reducing staff burnout and addressing gaps in caregiving.